Registration Dossier

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1979
Report date:
1979

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
yes
Remarks:
unknown concentration in vehicle, uncommon dose selection, high dose volume in PEG
GLP compliance:
no
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
3,3'-(1,4-phenylenediimino)bis[4,5,6,7-tetrachloro-1H-isoindol-1-one]
EC Number:
226-999-5
EC Name:
3,3'-(1,4-phenylenediimino)bis[4,5,6,7-tetrachloro-1H-isoindol-1-one]
Cas Number:
5590-18-1
Molecular formula:
C22H6Cl8N4O2
IUPAC Name:
3,3'-(1,4-phenylenediimino)bis(4,5,6,7-tetrachloro-1H-isoindol-1-one)
Constituent 2
Chemical structure
Reference substance name:
mono/bis-methoxy derivatives
Molecular formula:
C22-24H6-12Cl6-8N4O2-4
IUPAC Name:
mono/bis-methoxy derivatives
Test material form:
solid: bulk
Specific details on test material used for the study:
- Physical state: solid
- Analytical purity: no data

Test animals

Species:
rat
Strain:
other: Tif: RAif (SPF)
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 7 to 8 weeks
- Mean weight at study initiation per treatment group: males 193-208 g (maximum SD: 13.4 g); females 172-188 g (maximum SD: 9.4)
- Fasting period before study: overnight
- Housing: groups of 5 in Macrolon cages (type 3)
- Diet (e.g. ad libitum): NAFAG, Gossau SG, CH; ad lib.
- Water (e.g. ad libitum): not specified; ad lib.
- Acclimation period: at least 4 days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22+-2
- Humidity (%):55+-10
- Photoperiod (hrs dark / hrs light): 10/14

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
polyethylene glycol
Details on oral exposure:
VEHICLE
- Concentration in vehicle: no data

MAXIMUM DOSE VOLUME APPLIED: 10 and 20 mL/kg bw
Doses:
2000, 3000, 4000 and 5000 mg/kg bw (5000 mg/kg bw was reported to be the highest possible dose)
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Physical condition and rate of deaths were monitored throughout the whole observation period. Bodyweights were recorded immediately prior to dosing (control weights) and at 7 and 14 days.
- Necropsy of survivors performed: yes. The animals were submitted at random to a necropsy at the end of the observation period.

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 5 000 mg/kg bw
Based on:
test mat.
Remarks on result:
other: No mortality observed.
Mortality:
No mortality observed.
Clinical signs:
other: Dyspnoea, exophthalmus, curved position and ruffled fur were observed in all treatment groups and were reversible within at least 8 days (2000-3000 mg treatment) or 9 days (>=4000 mg).
Gross pathology:
No substance-related gross organ changes were seen.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met